4887.T
Get informed when a big investor buys or sells
+ Follow| Market cap | $188.18 Billion |
|---|---|
| Enterprise Value | $303.99 Billion |
| Dividend Yield | $56.00 (3.44%) |
| Earnings per Share | $90.4 |
| Beta | 0.03 |
| Outstanding Shares | 115,465,714 |
| P/E Ratio | 21.61 |
|---|---|
| PEG | -55.04 |
| Price to Sales | 0.87 |
| Price to Book Ratio | 0.85 |
| Enterprise Value to Revenue | 1.41 |
| Enterprise Value to EBIT | 19.55 |
| Enterprise Value to Net Income | 35 |
| Total Debt to Enterprise | 0.49 |
| Debt to Equity | 0.67 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Sawai Group Holdings Co., Ltd., together with its associated companies, focuses on the entire lifecycle of generic medications, from their initial research and development to manufacturing and commercialization. The company's primary ope...